We are live on ! Find out more
T. Rowe Price Investment Management

T. Rowe Price Investment Management Portfolio holdings

AUM $145B
1-Year Est. Return 22.78%
 

T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.

This Fund
S&P 500
This Quarter Est. Return
+9.67%
1 Year Est. Return
+22.78%
3 Year Est. Return
+69.87%
5 Year Est. Return
10 Year Est. Return
AUM
$130B
AUM Growth
+$5.15B
Cap. Flow
-$3.34B
Cap. Flow %
-2.56%
Top 10 Hldgs %
16.41%
Holding
577
New
38
Increased
261
Reduced
232
Closed
36

Top Buys

Rank Stock Value
1
EFX icon
Equifax
EFX
+$715M
2
LIN icon
Linde
LIN
+$549M
3
XEL icon
Xcel Energy
XEL
+$547M
4
ICE icon
Intercontinental Exchange
ICE
+$533M
5
ABBV icon
AbbVie
ABBV
+$503M

Sector Composition

Rank Sector Weight
1 Technology 23.49%
2 Healthcare 22.34%
3 Financials 13.96%
4 Industrials 11.89%
5 Consumer Discretionary 11.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FATE icon
526
Fate Therapeutics
FATE
$309M
$4.38M ﹤0.01%
433,869
+27,725
+7% +$521K
TDUP icon
527
ThredUp
TDUP
$410M
$3.4M ﹤0.01%
2,598,755
-655,748
-20% -$899K
MCW
528
DELISTED
Mister Car Wash
MCW
$3.4M ﹤0.01%
+368,731
New +$3.42M
NVCR icon
529
NovoCure
NVCR
$2.04B
$3.31M ﹤0.01%
+45,059
New +$3.39M
TNYA icon
530
Tenaya Therapeutics
TNYA
$169M
$3.15M ﹤0.01%
1,564,745
VZIO
531
DELISTED
VIZIO Holding Corp.
VZIO
$2.89M ﹤0.01%
+389,450
New +$3.77M
EB
532
DELISTED
Eventbrite
EB
$2.83M ﹤0.01%
483,154
-31,572
-6% -$206K
OLPX
533
DELISTED
Olaplex Holdings
OLPX
$2.58M ﹤0.01%
494,396
-1,562,878
-76% -$9.28M
RPID icon
534
Rapid Micro Biosystems
RPID
$85.3M
$2.48M ﹤0.01%
2,194,185
-452,427
-17% -$1.1M
IMRX icon
535
Immuneering
IMRX
$333M
$2.22M ﹤0.01%
458,233
GO icon
536
Grocery Outlet
GO
$1.05B
$1.89M ﹤0.01%
64,766
-61,760
-49% -$1.94M
HZN
537
DELISTED
Horizon Global Corporation
HZN
$1.77M ﹤0.01%
4,561,534
HYFM icon
538
Hydrofarm Holdings
HYFM
$8.05M
$1.2M ﹤0.01%
77,347
+54,011
+231% +$1.23M
BOAC.WS
539
DELISTED
Bluescape Opportunities Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
BOAC.WS
$106K ﹤0.01%
659,463
-1,488,512
-69% -$189K
ADVWW
540
DELISTED
Advantage Solutions Warrant
ADVWW
$81K ﹤0.01%
579,413
ABM icon
541
ABM Industries
ABM
$2.82B
-710,358
Closed -$27.2M
ALKS icon
542
Alkermes
ALKS
$8.37B
-4,562,808
Closed -$102M
ARRY icon
543
Array Technologies
ARRY
$801M
-2,086,179
Closed -$34.6M
CABO icon
544
Cable One
CABO
$195M
-298,185
Closed -$254M
CCCC icon
545
C4 Therapeutics
CCCC
$480M
-547,667
Closed -$4.8M
DECK icon
546
Deckers Outdoor
DECK
$12.5B
-3,019,578
Closed -$157M
DKNG icon
547
DraftKings
DKNG
$12.5B
-8,077,070
Closed -$122M
DOCU
548
DocuSign
DOCU
$11.1B
-2,518,551
Closed -$135M
EXEL icon
549
Exelixis
EXEL
$12.5B
-4,700,190
Closed -$73.7M
GENI icon
550
Genius Sports
GENI
$2.14B
-1,906,493
Closed -$7M

Similar funds

T. Rowe Price Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, T. Rowe Price Investment Management held 577 positions worth $130B, up 4.1% from $125B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Investment Management's Q4 2022 filing shows 38 new, 261 increased, 232 reduced and 36 closed positions. Its largest new stake was Xcel Energy: 8,228,100 shares worth $577M. The largest sale was Alphabet (Google) Class C, an estimated $948M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Investment Management's largest Q4 2022 buy was Xcel Energy: 8,228,100 shares worth $577M.
  • T. Rowe Price Investment Management added most to Equifax in Q4 2022, an estimated $715M increase.
  • T. Rowe Price Investment Management's biggest Q4 2022 reduction was TE Connectivity, cutting an estimated $756M.
  • T. Rowe Price Investment Management fully exited Alphabet (Google) Class C in Q4 2022, selling an estimated $948M.
  • T. Rowe Price Investment Management's ten largest holdings make up 16% of its $130B portfolio in Q4 2022.
  • T. Rowe Price Investment Management opened 38 new positions and closed 36 in Q4 2022.
  • T. Rowe Price Investment Management's portfolio value rose 4.1% quarter-over-quarter to $130B.

Based on T. Rowe Price Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.